Read Time:9 Second
Natco Pharma Limited has informed the Exchange regarding a press release dated February 14, 2026, titled “NATCO receives approval from Central Drugs Standard Control Organisation (CDSCO) for Semaglutide in India”. |SUBJECT: Press Release
Happy
0
0 %
Sad
0
0 %
Excited
0
0 %
Sleepy
0
0 %
Angry
0
0 %
Surprise
0
0 %